Additionally, several substances present in SLE patients contribute to the activation of the NLRP3 inflammasome within different cell types, including self-derived dsDNA [41], anti-dsDNA antibodies [123], and neutrophil extracellular traps (NETs) [124]. This evidence concerns the gene NLRP3 and systemic lupus erythematosus.